Md. Code, Health - General § 21-2A-03
This is the official text of Md. Code, Health - General § 21-2A-03, part of Maryland’s Code, Health - General — covers public health regulation.
Not legal advice. This page reproduces the official text of a government statute for reference only. Laws change, and how a statute applies depends on your specific facts. For advice about your situation, consult a licensed attorney in your state.
§21–2A–03.
Official statutory text
(a) The Department shall implement the Program, subject to the availability of funds.
(b) The Secretary may:
(1) Assign responsibility for the operation of the Program to any unit in the Department;
(2) Contract with any qualified person for the efficient and economical operation of the Program; and
(3) Identify and publish a list of monitored prescription drugs that have a low potential for abuse by individuals.
(c) Except as provided in subsection (d) of this section, each dispenser shall submit prescription monitoring data and naloxone medication data to the Program by electronic means, in accordance with regulations adopted by the Secretary.
(d) The Secretary, for good cause shown, may authorize a dispenser to submit prescription monitoring data or naloxone medication data by an alternative form of submission.
(e) The Secretary, in consultation with the Maryland Health Care Commission and the Board, shall:
(1) Determine the appropriate technology to support the operation of the Program; and
(2) Educate dispensers, prescribers, pharmacists, prescriber delegates, pharmacist delegates, and consumers about the purpose and operation of the Program.
(f) (1) The Secretary shall grant a waiver to a pharmacy that dispenses medications to an inpatient hospice from reporting to the Program prescription monitoring data for hospice inpatients if:
(i) The pharmacy demonstrates how it will distinguish hospice inpatients from other consumers receiving medications from the pharmacy; and
(ii) The pharmacy agrees that it will be subject to onsite, unannounced inspections by the Department to verify its reporting of the prescription data of consumers who are not hospice inpatients.
(2) A waiver granted under this subsection may remain in effect for up to 2 years.
(3) The Secretary may establish an application process for a pharmacy to apply for a waiver under this subsection.
(b) The Secretary may:
(1) Assign responsibility for the operation of the Program to any unit in the Department;
(2) Contract with any qualified person for the efficient and economical operation of the Program; and
(3) Identify and publish a list of monitored prescription drugs that have a low potential for abuse by individuals.
(c) Except as provided in subsection (d) of this section, each dispenser shall submit prescription monitoring data and naloxone medication data to the Program by electronic means, in accordance with regulations adopted by the Secretary.
(d) The Secretary, for good cause shown, may authorize a dispenser to submit prescription monitoring data or naloxone medication data by an alternative form of submission.
(e) The Secretary, in consultation with the Maryland Health Care Commission and the Board, shall:
(1) Determine the appropriate technology to support the operation of the Program; and
(2) Educate dispensers, prescribers, pharmacists, prescriber delegates, pharmacist delegates, and consumers about the purpose and operation of the Program.
(f) (1) The Secretary shall grant a waiver to a pharmacy that dispenses medications to an inpatient hospice from reporting to the Program prescription monitoring data for hospice inpatients if:
(i) The pharmacy demonstrates how it will distinguish hospice inpatients from other consumers receiving medications from the pharmacy; and
(ii) The pharmacy agrees that it will be subject to onsite, unannounced inspections by the Department to verify its reporting of the prescription data of consumers who are not hospice inpatients.
(2) A waiver granted under this subsection may remain in effect for up to 2 years.
(3) The Secretary may establish an application process for a pharmacy to apply for a waiver under this subsection.
Status: in_force · Read it on the official government site
Need a lawyer in Maryland?
Find a Maryland lawyer
About this page: Statute text is reproduced from official government publishers via the
Open US Law dataset
(Vaquill AI, snapshot v2026.08, CC BY 4.0). Primary legislative text like this is public domain under the government-edicts doctrine
(Georgia v. Public.Resource.Org, 2020). We link every section back to its official source so you can verify it independently.